Abiopharma

🔍 Sutaria Saumya (Executive)

Company: TENET HEALTHCARE CORP (THC)

Report Date: 2025-08-29

Detailed Transactions and Holdings:

• Acquired 53,341 shares of Common Stock (Direct)
  Date: 2025-08-29 | Code: M | equity_swap_involved: false | shares_owned_after: 528,706.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 27,087 shares of Common Stock at $184.33 per share (Direct)
  Date: 2025-08-29 | Code: F | equity_swap_involved: false | shares_owned_after: 501,619.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 54,174 shares of Common Stock at $184.33 per share (Direct)
  Date: 2025-08-29 | Code: F | equity_swap_involved: false | shares_owned_after: 447,445.00 | transaction_form_type: 4 | Footnotes: F4, F3
• Sold 53,341 shares of 2021 September Restricted Stock Units (Derivative)
  Date: 2025-08-29 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F5, F5, F5, F6

Footnotes:

• F1: Restricted stock units convert into common stock on a one-for-one basis.
• F2: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
• F3: Represents the closing price of the common stock of the Issuer on September 29, 2025.
• F4: Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units.
• F5: The restricted stock units were granted on September 1, 2021, pursuant to the 2019 Stock Incentive Plan and vested in full on August 29, 2025 (the business day prior to September 1, 2025, which fell on a federal holiday).
• F6: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.